➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Johnson and Johnson
Express Scripts
Baxter
Medtronic

Last Updated: September 23, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR PERAMPANEL

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Perampanel

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00368472 ↗ 4-Year Open-Label Extension Phase of the Parallel-Group Study of E2007 in Patients With Refractory Partial Seizures Completed Eisai Inc. Phase 2 2006-10-01 The purpose of this study is to determine the safety of perampanel given as adjunctive, long-term treatment in patients with refractory partial onset seizures.
NCT00505284 ↗ An Evaluation of the Efficacy and Safety of E2007 in Patients With Painful Diabetic Neuropathy Completed Eisai Limited Phase 2/Phase 3 2007-06-01 The purpose of this study is to determine the efficacy and safety of Perampanel in patients with painful diabetic neuropathy.
NCT00505284 ↗ An Evaluation of the Efficacy and Safety of E2007 in Patients With Painful Diabetic Neuropathy Completed Eisai Inc. Phase 2/Phase 3 2007-06-01 The purpose of this study is to determine the efficacy and safety of Perampanel in patients with painful diabetic neuropathy.
NCT00505622 ↗ Evaluation of the Long-term Safety, Tolerability, and Efficacy of Perampanel (E2007) as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Subjects With Motor Fluctuations Terminated Eisai Limited Phase 3 2007-07-01 This is a multicentre, open-label extension study to evaluate the long-term safety, tolerability, and efficacy of Perampanel (E2007) as an adjunctive therapy in levodopa treated PD subjects with motor fluctuations. All subjects who have completed E2007-E044-213 or E2007-G000-309 will be candidates for entering this extension trial, provided that they meet the inclusion/exclusion criteria and have completed the core study, up to and including the final efficacy visit.
NCT00566462 ↗ Assessment of Perampanel (E2007) on Synaptic Dopamine in Mild-moderate PD Patients: A Pilot Study With [^123I]-IBZM SPECT Terminated Eisai Inc. Phase 2 2007-10-01 This is a two-arm, double-blind, placebo-controlled study.
NCT00592774 ↗ Dose-Tolerability Titration Study to Evaluate The Efficacy And Safety Of Perampanel (E2007) In Patients With Post-Herpetic Neuralgia (PHN) Completed Eisai Inc. Phase 2 2008-01-01 The purpose of the study is to determine the efficacy and safety of Perampanel (E2007) in patients with Post-Herpetic Neuralgia (PHN).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Perampanel

Condition Name

Condition Name for Perampanel
Intervention Trials
Epilepsy 13
Healthy 4
Refractory Partial Seizures 4
Parkinson's Disease 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Perampanel
Intervention Trials
Seizures 22
Epilepsy 19
Epilepsies, Partial 4
Parkinson Disease 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Perampanel

Trials by Country

Trials by Country for Perampanel
Location Trials
United States 157
Japan 43
China 16
Spain 13
Canada 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Perampanel
Location Trials
Florida 11
New York 9
Maryland 8
Colorado 8
Arizona 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Perampanel

Clinical Trial Phase

Clinical Trial Phase for Perampanel
Clinical Trial Phase Trials
Phase 4 11
Phase 3 12
Phase 2/Phase 3 2
[disabled in preview] 27
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Perampanel
Clinical Trial Phase Trials
Completed 20
Recruiting 17
Not yet recruiting 12
[disabled in preview] 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Perampanel

Sponsor Name

Sponsor Name for Perampanel
Sponsor Trials
Eisai Inc. 35
Eisai Co., Ltd. 7
Eisai Limited 3
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Perampanel
Sponsor Trials
Industry 47
Other 24
NIH 4
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Baxter
Moodys
Merck
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.